| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |